Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3649 Target Snapshot

Xanthine dehydrogenase/oxidase · SINGLE PROTEIN · Bos taurus

1,721Compounds
248Assays
5Approved Drugs
1,523.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P80457. Use UniProt P80457 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P80457 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Xanthine dehydrogenase/oxidase as ChEMBL target CHEMBL3649, mapped to UniProt P80457. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Xanthine dehydrogenase/oxidase
SINGLE PROTEIN · Bos taurus
As of 2026-09-13
ChEMBL target ID
CHEMBL3649
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P80457
Xanthine dehydrogenase/oxidase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Xanthine dehydrogenase/oxidase is the right protein anchor across sources, using UniProt P80457 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelXanthine dehydrogenase/oxidase
UniProt AccessionP80457
Component TypeProtein
Sequence Length1332 aa

Xanthine dehydrogenase/oxidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Xanthine dehydrogenase/oxidase, mapped to UniProt P80457. Sequence length is 1332 aa.

Mapped IDP80457
Review nameXanthine dehydrogenase/oxidase
OrganismBos taurus
Clinical Profile

Clinical Phase Distribution

5
Approved
3
Phase III
6
Phase II
Assay Mix

Activity Type Distribution

IC501,429.0
KI63.0
EC5030.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1164729 9.92 Ki 0.12 Approved
CHEMBL1467 9.27 Kd 0.54 Approved
CHEMBL3331617 9.05 Ki 0.9 Preclinical
CHEMBL5426192 8.89 IC50 1.3 Preclinical
CHEMBL5408075 8.88 IC50 1.32 Preclinical
CHEMBL5395447 8.87 IC50 1.35 Preclinical
CHEMBL5405574 8.85 IC50 1.4 Preclinical
CHEMBL5408526 8.8 IC50 1.58 Preclinical
CHEMBL5436044 8.78 IC50 1.67 Preclinical
CHEMBL3667863 8.77 IC50 1.7 Preclinical
Distribution

pChEMBL Value Distribution

143
5.0
123
5.5
69
6.0
75
6.5
182
7.0
191
7.5
214
8.0
37
8.5
4
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

FEBUXOSTAT
CHEMBL1164729
Approved 2008
ALLOPURINOL
CHEMBL1467
Approved 1966
Assay Landscape

Assay Landscape

248
Total Assays
1,206
Tested Compounds
1
Assay Types
Binding — 248 assays, 1,206 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 246 1,203 6.5
cell-free format 1 1 6.4
tissue-based format 1 2 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine